Literature DB >> 33771989

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.

Eilam Yeini1, Paula Ofek1, Sabina Pozzi1, Nitzan Albeck1,2, Dikla Ben-Shushan1, Galia Tiram1, Sapir Golan1, Ron Kleiner1, Ron Sheinin3, Sahar Israeli Dangoor1, Shlomit Reich-Zeliger4, Rachel Grossman5, Zvi Ram5, Henry Brem6, Thomas M Hyde7,8,9, Prerna Magod10, Dinorah Friedmann-Morvinski2,10, Asaf Madi3, Ronit Satchi-Fainaro11,12.   

Abstract

Glioblastoma (GB) is a highly invasive type of brain cancer exhibiting poor prognosis. As such, its microenvironment plays a crucial role in its progression. Among the brain stromal cells, the microglia were shown to facilitate GB invasion and immunosuppression. However, the reciprocal mechanisms by which GB cells alter microglia/macrophages behavior are not fully understood. We propose that these mechanisms involve adhesion molecules such as the Selectins family. These proteins are involved in immune modulation and cancer immunity. We show that P-selectin mediates microglia-enhanced GB proliferation and invasion by altering microglia/macrophages activation state. We demonstrate these findings by pharmacological and molecular inhibition of P-selectin which leads to reduced tumor growth and increased survival in GB mouse models. Our work sheds light on tumor-associated microglia/macrophage function and the mechanisms by which GB cells suppress the immune system and invade the brain, paving the way to exploit P-selectin as a target for GB therapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33771989     DOI: 10.1038/s41467-021-22186-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

Review 1.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

Review 2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

Review 3.  Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.

Authors:  David H Gutmann; Helmut Kettenmann
Journal:  Neuron       Date:  2019-11-06       Impact factor: 17.173

Review 4.  The brain tumor microenvironment.

Authors:  Nikki A Charles; Eric C Holland; Richard Gilbertson; Rainer Glass; Helmut Kettenmann
Journal:  Glia       Date:  2011-03-28       Impact factor: 7.452

5.  Dental treatment requirements of active duty Navy and Marine Corps personnel.

Authors:  G J Spinks; N W Schneider
Journal:  Mil Med       Date:  1981-01       Impact factor: 1.437

Review 6.  The role of microglia and macrophages in glioma maintenance and progression.

Authors:  Dolores Hambardzumyan; David H Gutmann; Helmut Kettenmann
Journal:  Nat Neurosci       Date:  2016-01       Impact factor: 24.884

Review 7.  Emerging insights into the molecular and cellular basis of glioblastoma.

Authors:  Gavin P Dunn; Mikael L Rinne; Jill Wykosky; Giannicola Genovese; Steven N Quayle; Ian F Dunn; Pankaj K Agarwalla; Milan G Chheda; Benito Campos; Alan Wang; Cameron Brennan; Keith L Ligon; Frank Furnari; Webster K Cavenee; Ronald A Depinho; Lynda Chin; William C Hahn
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

Review 8.  Microglia Function in the Central Nervous System During Health and Neurodegeneration.

Authors:  Marco Colonna; Oleg Butovsky
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Macrophage activation and polarization: nomenclature and experimental guidelines.

Authors:  Peter J Murray; Judith E Allen; Subhra K Biswas; Edward A Fisher; Derek W Gilroy; Sergij Goerdt; Siamon Gordon; John A Hamilton; Lionel B Ivashkiv; Toby Lawrence; Massimo Locati; Alberto Mantovani; Fernando O Martinez; Jean-Louis Mege; David M Mosser; Gioacchino Natoli; Jeroen P Saeij; Joachim L Schultze; Kari Ann Shirey; Antonio Sica; Jill Suttles; Irina Udalova; Jo A van Ginderachter; Stefanie N Vogel; Thomas A Wynn
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

View more
  11 in total

Review 1.  Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.

Authors:  Lizhi Pang; Fatima Khan; Amy B Heimberger; Peiwen Chen
Journal:  Trends Cancer       Date:  2022-05-24

Review 2.  Pharmacological targeting of the tumor-immune symbiosis in glioblastoma.

Authors:  Lizhi Pang; Fatima Khan; Madeline Dunterman; Peiwen Chen
Journal:  Trends Pharmacol Sci       Date:  2022-05-07       Impact factor: 17.638

Review 3.  Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases.

Authors:  Maiara N Lima; Maria C Barbosa-Silva; Tatiana Maron-Gutierrez
Journal:  Front Cell Neurosci       Date:  2022-06-15       Impact factor: 6.147

4.  Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.

Authors:  Wen-Hao Hsu; Fatima Khan; Madeline Dunterman; Lizhi Pang; Wenjing Xuan; Derek A Wainwright; Atique U Ahmed; Amy B Heimberger; Maciej S Lesniak; Peiwen Chen
Journal:  Cancer Immunol Res       Date:  2022-06-03       Impact factor: 12.020

5.  Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment.

Authors:  Lena Neufeld; Eilam Yeini; Noa Reisman; Yael Shtilerman; Dikla Ben-Shushan; Sabina Pozzi; Asaf Madi; Galia Tiram; Anat Eldar-Boock; Shiran Ferber; Rachel Grossman; Zvi Ram; Ronit Satchi-Fainaro
Journal:  Sci Adv       Date:  2021-08-18       Impact factor: 14.136

Review 6.  Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma.

Authors:  Chaitanya Tondepu; Lohitash Karumbaiah
Journal:  Adv Healthc Mater       Date:  2021-12-29       Impact factor: 11.092

Review 7.  Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.

Authors:  Johannes K Andersen; Hrvoje Miletic; Jubayer A Hossain
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

8.  Differential effect of tantalum nanoparticles versus tantalum micron particles on immune regulation.

Authors:  Yan Sun; Tuozhou Liu; Hongkun Hu; Zixuan Xiong; Kai Zhang; Xi He; Wenbin Liu; Pengfei Lei; Yihe Hu
Journal:  Mater Today Bio       Date:  2022-06-25

Review 9.  Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.

Authors:  Jun Ma; Clark C Chen; Ming Li
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors.

Authors:  Adva Krivitsky; Sabina Pozzi; Eilam Yeini; Sahar Israeli Dangoor; Tal Zur; Sapir Golan; Vadim Krivitsky; Nitzan Albeck; Evgeny Pisarevsky; Paula Ofek; Asaf Madi; Ronit Satchi-Fainaro
Journal:  Pharmaceutics       Date:  2021-12-20       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.